11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
The DOI matches its Crossref record; 398 of the 412 references it cites were found in a registry or an index.
Abstract
11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) interconverts inactive cortisone and active cortisol. Although bidirectional, in vivo it is believed to function as a reductase generating active glucocorticoid at a prereceptor level, enhancing glucocorticoid receptor activation. In this review, we discuss both the genetic and enzymatic characterization of 11beta-HSD1, as well as describing its role in physiology and pathology in a tissue-specific manner. The molecular basis of cortisone reductase deficiency, the putative "11beta-HSD1 knockout state" in humans, has been defined and is caused by intronic mutations in HSD11B1 that decrease gene transcription together with mutations in hexose-6-phosphate dehydrogenase, an endoluminal enzyme that provides reduced nicotinamide-adenine dinucleotide phosphate as cofactor to 11beta-HSD1 to permit reductase activity. We speculate that hexose-6-phosphate dehydrogenase activity and therefore reduced nicotinamide-adenine dinucleotide phosphate supply may be crucial in determining the directionality of 11beta-HSD1 activity. Therapeutic inhibition of 11beta-HSD1 reductase activity in patients with obesity and the metabolic syndrome, as well as in glaucoma and osteoporosis, remains an exciting prospect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cortisone and prednisone are inactive prohormones that must be reduced to cortisol or prednisolone by hepatic 11HSD1 to bind to and activate the glucocorticoid receptor (GR) (45, 587).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [587]
In the citing paper
“other health outcomes associated with better quality of life improved, including sleep apnoea136 and mobility137.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [136]
In the citing paper
“the glucocorticoid sensitivity may be different among the different individuals and among the different tissues in the same individual, due also to polymorphisms of both glucocorticoid receptor (25)(26)(27)(28) and 11-hydroxysteroid-dehydrogenase type 1 genes (29,30).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [29]
In the citing paper
“HSD11B2 functions exclusively as an oxidative enzyme, inactivating cortisol to cortisone [108].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [108]
In the citing paper
“while 17OHP and cortisol can be either 5α- or 5β-reduced, 11-deoxycortisol and cortisone are predominantly 5β-reduced [108].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [108]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541 · cited 1×
“Immunomodulation represents an important facet of glucocorticoid physiology and inflammation therapy and is manifested by the regulation of cytokine production and immune cell function (324).”
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 1×
“Mice overexpressing 11 -HSD1 under the aP2 promoter have enhanced adipocyte differentiation (as measured by increased fat cell size) as a consequence of increased adipose tissue corticosteroid concentrations (139) (see Section VII.”
Short-chain dehydrogenases/reductases (SDR)
Jörnvall, H., Persson, B., Krook, M., Atrian, S., Gonzalez-Duarte, R., Jeffery, J., & Ghosh, D. (1995) · Biochemistry · doi:10.1021/bi00018a001 · Cited by 1,249 · cited 3×
“Also known as short-chain alcohol dehydrogenases (35) or sec (secondary) alcohol dehydrogenases (36), members of this family were originally classified as having 250–300 residues (classical family) with an N-terminal cofactor-binding domain and a centrally located active site, although some enzymes now have more than…”
Edwards, C. R. W., Burt, D., Mcintyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,068
Self-citationCole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., & Schütz, G. (1995) · Genes & Development · doi:10.1101/gad.9.13.1608 · Cited by 946 · cited 1×
“Within the fetal rat lung, corticosteroids increased 11-oxoreductase activity, which in turn resulted in an increase in surfactant synthesis (71), a glucocorticoiddependent process (336) essential for normal lung maturation.”
Impaired Energy Homeostasis in C/EBPα Knockout Mice
Wang, N.-D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R., & Darlington, G. J. (1995) · Science · doi:10.1126/science.7652557 · Cited by 929
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Self-citationANTI-ESCHERICHIA COLI ALPHA-HAEMOLYSIN IN CONTROL AND PATIENT SERA
Emody, L., Batai, I., Kerényi, M., Székely, J., & Polyak, L. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90183-0 · Cited by 800
Research works printed but not linked: 6
- Bush, 1969, 11β-Hydroxysteroid dehydrogenase: contrast between studies in vivo and studies in vitro., Adv Biosci, 3, 23
- Taylor, 1990, Corticosteroid 11-reductase deficiency: steroid studies in a further family, J Clin Invest, 13, P238
- Burtt, 2003, Haplotype-based association studies of HSD11B1 and abdominal obesity, 117
- Bujalska, 2000, Glucocorticoids, 11β-hydroxysteroid dehydrogenase and obesity, 158
- Taylor, 1984, Cortisone reductase deficiency: evidence for a new inborn error in metabolism of adrenal steroids, J Endocrinol, 102, 89
- Savage, 1991, Increased metabolic clearance of cortisol in corticosteroid 11-reductase deficiency, J Endocrinol, 129, 219
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Self-citationGlucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
“11β-hydroxysteroid dehydrogenases regulate the interconversion between cortisone and hormonally active cortisol, and play a role in the regulation of glucocorticoid activity [72].”
Frailty and sarcopenia: The potential role of an aged immune system
Wilson, D., Jackson, T., Sapey, E., & Lord, J. M. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.01.006 · Cited by 573
“11 HSD1 activity increases with age and is induced by cytokines including TNF and IL-6 (Tomlinson et al., 2004).”
Interactions between sleep, stress, and metabolism: From physiological to pathological conditions
Hirotsu, C., Tufik, S., & Andersen, M. L. (2015) · Sleep Science · doi:10.1016/j.slsci.2015.09.002 · Cited by 495
“[111] Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, et al.”
The Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids
Oster, H., Challet, E., Ott, V., Arvat, E., de Kloet, E. R., Dijk, D.-J., Lightman, S., Vgontzas, A., & Van Cauter, E. (2017) · Endocrine Reviews · doi:10.1210/er.2015-1080 · Cited by 548
Bays, H. E., González-Campoy, J. M., Bray, G. A., Kitabchi, A. E., Bergman, D. A., Schorr, A. B., Rodbard, H. W., & Henry, R. R. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.343 · Cited by 530
Glucocorticoids, metabolism and metabolic diseases
Vegiopoulos, A., & Herzig, S. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.015 · Cited by 535
“Type 1 is predominantly reductive, thus promoting local regeneration of cortisol, while type 2 resembles the oxidative isozyme catalyzing the inactivation of cortisol [142,143].”
Correlation of Obesity and Osteoporosis: Effect of Fat Mass on the Determination of Osteoporosis
Zhao, L.-J., Jiang, H., Papasian, C. J., Maulik, D., Drees, B., Hamilton, J., & Deng, H.-W. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070813 · Cited by 528
“adipocytes, 11b-HSD1 is also present in osteoblasts and osteoclasts.((92,93)) The expression of osteoblastic 11b-HSD1”
Glucocorticoids and cardiovascular disease
Walker, B. R. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0455 · Cited by 529
El-Saber Batiha, G., Magdy Beshbishy, A., El-Mleeh, A., M. Abdel-Daim, M., & Prasad Devkota, H. (2020) · Biomolecules · doi:10.3390/biom10030352 · Cited by 461
Slominski, A. T., Zmijewski, M. A., Skobowiat, C., Zbytek, B., Slominski, R. M., & Steketee, J. D. (2012) · Advances in Anatomy, Embryology and Cell Biology · doi:10.1007/978-3-642-19683-6 · Cited by 496
“Cortisol can also be transformed to cortisone by NADP+ dependent enzyme 11 -HSD2 that acts exclusively as a dehydrogenase (Tomlinson et al., 2004).”
Aguirre, J. I., Plotkin, L. I., Stewart, S. A., Weinstein, R. S., Parfitt, A. M., Manolagas, S. C., & Bellido, T. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060107 · Cited by 494
Reduced Cortisol Metabolism during Critical Illness
Boonen, E., Vervenne, H., Meersseman, P., Andrew, R., Mortier, L., Declercq, P. E., Vanwijngaerden, Y.-M., Spriet, I., Wouters, P. J., Vander Perre, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214969 · Cited by 477
Obesity and androgens: facts and perspectives
Pasquali, R. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.10.054 · Cited by 469
Slominski (2012) · doi:10.1007/978-3-642-19683-6_1 · Cited by 461
Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450
“Thereby, they modulate systemic and tissuespecific glucocorticoid action [74,108].”
Mechanisms of Glucocorticoid-Induced Insulin Resistance
Geer, E. B., Islam, J., & Buettner, C. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.10.005 · Cited by 392
Mortality in Patients with Pituitary Disease
Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392
Self-citationStress and obesity: the role of the hypothalamic–pituitary–adrenal axis in metabolic disease
Bose, M., Oliván, B., & Laferrère, B. (2009) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32832fa137 · Cited by 358
Macfarlane, D. P., Forbes, S., & Walker, B. R. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0054 · Cited by 385
“The enzyme 11b-HSD1 amplifies local glucocorticoid levels, influencing receptor activation within tissues, and is highly expressed in adipose tissue and the liver (reviewed in Seckl & Walker 2001, Tomlinson et al. 2004).”
Bone loss in inflammatory disorders
Hardy, R., & Cooper, M. S. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0568 · Cited by 365
“It is now clear that the levels of active glucocorticoids present within the circulation can differ from that in the tissues due to tissue metabolism of glucocorticoids by intracellular enzymes (Tomlinson et al. 2004).”
Self-citationGlucocorticoid-induced osteoporosis: an update
Mazziotti, G., Angeli, A., Bilezikian, J. P., Canalis, E., & Giustina, A. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.03.009 · Cited by 362
The Hypothalamic‐Pituitary‐Adrenal Axis Activity in Obesity and the Metabolic Syndrome
PASQUALI, R., VICENNATI, V., CACCIARI, M., & PAGOTTO, U. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.009 · Cited by 332
From excess adiposity to insulin resistance: The role of free fatty acids
Capurso, C., & Capurso, A. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.05.003 · Cited by 337
“The increase in VAT is also attributable to the glucocorticoid-induced increase in appetite, as well as to a glucocorticoid-dependent increase in adipocyte differentiation and decrease in adipocyte proliferation, both of which promote adipocyte hypertrophy (Tomlinson et al., 2004).”
Glucocorticoid sensitivity in health and disease
Quax, R. A., Manenschijn, L., Koper, J. W., Hazes, J. M., Lamberts, S. W. J., van Rossum, E. F. C., & Feelders, R. A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.183 · Cited by 310
Morris, M. J., Beilharz, J. E., Maniam, J., Reichelt, A. C., & Westbrook, R. F. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.002 · Cited by 285
Thyroid Function in Humans with Morbid Obesity
Michalaki, M. A., Vagenakis, A. G., Leonardou, A. S., Argentou, M. N., Habeos, I. G., Makri, M. G., Psyrogiannis, A. I., Kalfarentzos, F. E., & Kyriazopoulou, V. E. (2006) · Thyroid · doi:10.1089/thy.2006.16.73 · Cited by 295
Early-life stress, HPA axis adaptation, and mechanisms contributing to later health outcomes
Maniam, J., Antoniadis, C., & Morris, M. J. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00073 · Cited by 295
Weinstein, R. S., Wan, C., Liu, Q., Wang, Y., Almeida, M., O’Brien, C. A., Thostenson, J., Roberson, P. K., Boskey, A. L., Clemens, T. L., et al. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2009.00545.x · Cited by 276
“In addition, the age-dependant decrease in growth hormone and IGF-1 levels is associated with increased 11b-HSD1 expression (Tomlinson et al., 2004).”
Diagnosis and Treatment of Subclinical Hypercortisolism
Chiodini, I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2722 · Cited by 279
The link between stress and feeding behaviour
Maniam, J., & Morris, M. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.017 · Cited by 255
Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., & Wise, P. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0020 · Cited by 264
The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease
Odermatt, A. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00068.2011 · Cited by 257
“Chronically elevated 11 -HSD1 activity has been associated with various adverse metabolic effects (7, 142).”
Glucocorticoid receptor isoforms generate transcription specificity
Lu, N. Z., & Cidlowski, J. A. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.04.005 · Cited by 248
Metabolic functions of glucocorticoid receptor in skeletal muscle
Kuo, T., Harris, C. A., & Wang, J.-C. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.03.003 · Cited by 241
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?
Pofi, R., Caratti, G., Ray, D. W., & Tomlinson, J. W. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad016 · Cited by 209
“11 β -HSD1 is highly expressed in many tissues through - out the body including the liver, which has the highest level of expression, adipose (subcutaneous and intrabdominal), muscle, skin, brain, and bone (25).”
InfluentialSelf-citationThe Biological Actions of Dehydroepiandrosterone Involves Multiple Receptors
Webb, S. J., Geoghegan, T. E., Prough, R. A., & Michael Miller, K. K. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600569877 · Cited by 237
Cortisol assays and diagnostic laboratory procedures in human biological fluids
Gatti, R., Antonelli, G., Prearo, M., Spinella, P., Cappellin, E., & De Palo, E. F. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.04.011 · Cited by 214
Baias, M., Dumez, J.-N., Svensson, P. H., Schantz, S., Day, G. M., & Emsley, L. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4088874 · Cited by 209
Association of Adrenal Steroids With Hypertension and the Metabolic Syndrome in Blacks
Kidambi, S., Kotchen, J. M., Grim, C. E., Raff, H., Mao, J., Singh, R. J., & Kotchen, T. A. (2007) · Hypertension · doi:10.1161/01.hyp.0000253258.36141.c7 · Cited by 212
Metabolic comorbidities in Cushing's syndrome
Ferraù, F., & Korbonits, M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0354 · Cited by 187
Lavery, G. G., Walker, E. A., Draper, N., Jeyasuria, P., Marcos, J., Shackleton, C. H. L., Parker, K. L., White, P. C., & Stewart, P. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512635200 · Cited by 207
Self-citationGlucocorticoids and the regulation of growth hormone secretion
Mazziotti, G., & Giustina, A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.5 · Cited by 206
Molecular links between endocrine, nervous and immune system during chronic stress
Zefferino, R., Di Gioia, S., & Conese, M. (2021) · Brain and Behavior · doi:10.1002/brb3.1960 · Cited by 204
“…11β-hydroxysteroid dehydrogenase (11β-HSD) regulate cortisol levels: 11β-HSD1 is bidirectional but it is believed to act in vivo generating predominantly the active cortisol from the inactive cortisone, while, in contrast 11β-HSD2 acts to convert cortisol to cortisone (Tomlinson et al., 2004).”
Charmandari, E., Kino, T., Ichijo, T., & Chrousos, G. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0040 · Cited by 201
Adrenal Corticosteroid Biosynthesis, Metabolism, and Action
Arlt, W., & Stewart, P. M. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.002 · Cited by 195
Self-citationArgentieri, M. A., Nagarajan, S., Seddighzadeh, B., Baccarelli, A. A., & Shields, A. E. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.044 · Cited by 188
“Cortisol levels are further regulated by the HSD11β2 enzyme, which degrades cortisol to cortisone, whereas HSD11β1 catalyzes the conversion of the inactive cortisone to active cortisol (Tomlinson et al., 2004).”
11β-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects
Gathercole, L. L., Lavery, G. G., Morgan, S. A., Cooper, M. S., Sinclair, A. J., Tomlinson, J. W., & Stewart, P. M. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1050 · Cited by 196
Self-citationINVITED REVIEW: The usefulness of measuring glucocorticoids for assessing animal welfare
Ralph, C. R., & Tilbrook, A. J. (2016) · Journal of Animal Science · doi:10.2527/jas.2015-9645 · Cited by 179
“Effectively, this protects the target tissue from the actions of glucocorticoids and provides a pool of cortisone that can be used by metabolic tissues after conversion to cortisol by 11 β-HSD 1 (Tomlinson et al., 2004).”
InfluentialSherlock, M., Reulen, R. C., Alonso, A. A., Ayuk, J., Clayton, R. N., Sheppard, M. C., Hawkins, M. M., Bates, A. S., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1097 · Cited by 185
Self-citationCooper, M. S., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1412 · Cited by 183
Self-citationCortisol—cause and cure for metabolic syndrome?
Walker, B. R. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01998.x · Cited by 179
Cortón, M., Botella-Carretero, J. I., Benguría, A., Villuendas, G., Zaballos, A., San Millán, J. L., Escobar-Morreale, H. F., & Peral, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1665 · Cited by 175
Aging-associated alterations in epidermal function and their clinical significance
Wang, Z., Man, M.-Q., Li, T., Elias, P. M., & Mauro, T. M. (2020) · Aging · doi:10.18632/aging.102946 · Cited by 175
“Moreover, glucocorticoid action requires the peripheral conversion of cortisone to cortisol by 11β hydroxysteroid dehydrogenase 1 [41].”
Morgan, S. A., Sherlock, M., Gathercole, L. L., Lavery, G. G., Lenaghan, C., Bujalska, I. J., Laber, D., Yu, A., Convey, G., Mayers, R., et al. (2009) · Diabetes · doi:10.2337/db09-0525 · Cited by 167
“11!-HSD1 is an endo-lumenal enzyme that interconverts inactive (cortisone in humans and 11dehydrocorticosterone [11DHC] in rodents) and active glucocorticoids (cortisol in humans and corticosterone [CORT] in rodents) (4).”
Self-citationDehydroepiandrosterone as a regulator of immune cell function
Hazeldine, J., Arlt, W., & Lord, J. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.016 · Cited by 173
Morton, N. M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.024 · Cited by 163
Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma
Ma, R., Zhang, W., Tang, K., Zhang, H., Zhang, Y., Li, D., Li, Y., Xu, P., Luo, S., Cai, W., et al. (2013) · Nature Communications · doi:10.1038/ncomms3508 · Cited by 163
Barahona, M.-J., Sucunza, N., Resmini, E., Fernández-Real, J.-M., Ricart, W., Moreno-Navarrete, J.-M., Puig, T., Farrerons, J., & Webb, S. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0766 · Cited by 162
Inhibition of 11ß-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target
Wamil, M., & Seckl, J. R. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.06.001 · Cited by 163
Yang, K., Guan, H., Arany, E., Hill, D. J., & Cao, X. (2008) · The FASEB Journal · doi:10.1096/fj.07-100735 · Cited by 159
“The present data contrast with those in the literature showing an up-regulation of at least one of these three key components in the local glucocorticoid signaling in a variety of rodent models of obesity ( 61 ), including the recently reported mouse model of stress and high-fat diet-induced obesity in which both cort…”
Mechanisms of glucocorticoid action in bone
Canalis, E. (2005) · Current Osteoporosis Reports · doi:10.1007/s11914-005-0017-7 · Cited by 159
“Pre-receptor steroid regulation is critical to steroid action and is regulated by 11β-hydroxysteroid dehydrogenases (11β-HSDs), which are isoenzymes that catalyze the interconversion of hormonally active cortisol and inactive cortisone [ 42 ].”
Vega, C. C., Reyes-Castro, L. A., Bautista, C. J., Larrea, F., Nathanielsz, P. W., & Zambrano, E. (2015) · International Journal of Obesity · doi:10.1038/ijo.2013.150 · Cited by 158
“While the most likely source of maternal corticosterone is the adrenal, adipose tissue 11β-hydroxysteroid dehydrogenase-1 reductase can generate active corticosterone from inactive dehydrocorticosterone(47).”
Adrenal function and dysfunction in critically ill patients
Téblick, A., Peeters, B., Langouche, L., & den Berghe, G. V. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0185-7 · Cited by 172
Premature adrenarche: novel lessons from early onset androgen excess
Idkowiak, J., Lavery, G. G., Dhir, V., Barrett, T. G., Stewart, P. M., Krone, N., & Arlt, W. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0223 · Cited by 158
Self-citationChen, X., Hussain, S., Parveen, S., Zhang, S., Yang, Y., & Zhu, C. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712801323225 · Cited by 163
“11- -HSD1 is a key enzyme that acts as an NADPHdependent reductase, converting cortisone into cortisol and amplifying glucocorticoid action locally in a tissue specific manner [113].”
Janssen, J. A. M. J. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158178 · Cited by 180
Tissue Production of Cortisol by 11β‐Hydroxysteroid Dehydrogenase Type 1 and Metabolic Disease
WALKER, B. R., & ANDREW, R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.012 · Cited by 150
Regulation of Lipogenesis by Glucocorticoids and Insulin in Human Adipose Tissue
Gathercole, L. L., Morgan, S. A., Bujalska, I. J., Hauton, D., Stewart, P. M., & Tomlinson, J. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026223 · Cited by 150
Self-citationMultiplicity of Mammalian Reductases for Xenobiotic Carbonyl Compounds
Matsunaga, T., Shintani, S., & Hara, A. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.1 · Cited by 150
Kumari, M., Chandola, T., Brunner, E., & Kivimaki, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2105 · Cited by 141
Keynote review: The adipocyte as a drug discovery target
Nawrocki, A. R., & Scherer, P. E. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03569-5 · Cited by 153
Pasquali, R. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06569.x · Cited by 131
Glucocorticoids, osteocytes, and skeletal fragility: The role of bone vascularity
Weinstein, R. S. (2010) · Bone · doi:10.1016/j.bone.2009.06.030 · Cited by 136
“11β-HSD1 is expressed in osteoblasts (probably also in osteocytes) and represents a “fast forward” mechanism for tissue-specific amplification of the ambient glucocorticoid level [36,37].”
Wang, J., Sun, B., Hou, M., Pan, X., & Li, X. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.173 · Cited by 146
The glucocorticoid contribution to obesity
Spencer, S. J., & Tilbrook, A. (2011) · Stress · doi:10.3109/10253890.2010.534831 · Cited by 127
“This profile in particular may be associated with differential effects of GC at the adipose tissue level (Tomlinson et al. 2004).”
Cortisol Release From Adipose Tissue by 11β-Hydroxysteroid Dehydrogenase Type 1 in Humans
Stimson, R. H., Andersson, J., Andrew, R., Redhead, D. N., Karpe, F., Hayes, P. C., Olsson, T., & Walker, B. R. (2009) · Diabetes · doi:10.2337/db08-0969 · Cited by 128
Tomlinson, J. W., Finney, J., Gay, C., Hughes, B. A., Hughes, S. V., & Stewart, P. M. (2008) · Diabetes · doi:10.2337/db08-0495 · Cited by 131
Self-citationDebono, M., Harrison, R. F., Whitaker, M. J., Eckland, D., Arlt, W., Keevil, B. G., & Ross, R. J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3694 · Cited by 128
Association between Stress and the HPA Axis in the Atopic Dermatitis
Lin, T.-K., Zhong, L., & Santiago, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102131 · Cited by 127
Signalling mechanisms linking hepatic glucose and lipid metabolism
Weickert, M. O., & Pfeiffer, A. F. H. (2006) · Diabetologia · doi:10.1007/s00125-006-0295-3 · Cited by 127
“The highest levels of expression have been found in the liver, gonads, adipose tissue and the brain [90].”
Cheung, Y. Y., Kim, S. Y., Yiu, W. H., Pan, C., Jun, H.-S., Ruef, R. A., Lee, E. J., Westphal, H., Mansfield, B. C., & CHOU, J. Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30443 · Cited by 133
“The NADPH within the lumen of the ER is important for in vivo function of 11β-hydroxysteroid dehydrogenase-1 (47), an ER-associated oxoreductase that generates cortisol and/or corticosterone locally to modulate immune responses.”
Why is the management of glucocorticoid deficiency still controversial: a review of the literature
Crown, A., & Lightman, S. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02320.x · Cited by 128
Fernando, H. A., Chin, H.-F., Ton, S. H., & Kadir, K. A. (2013) · Journal of Diabetes Research · doi:10.1155/2013/190395 · Cited by 129
“Hence the ability of GA to improve stress-induced disturbances in the absence of adaptation needs to be investigated further.”
Cortisol metabolism in hypertension
Hammer, F., & Stewart, P. M. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.001 · Cited by 143
Self-citationVitlic, A., Lord, J. M., & Phillips, A. C. (2014) · AGE · doi:10.1007/s11357-014-9631-6 · Cited by 123
“This idea comes from the fact that activity of the enzyme capable of converting cortisone to active cortisol, 11β- hydroxysteroid dehydrogenase type 1 (11β-HSD1), is increased with the higher pro-inflammatory status, which is considered typical in the ageing process (Tomlinson et al. 2004).”
Giordano, R., Picu, A., Marinazzo, E., D’Angelo, V., Berardelli, R., Karamouzis, I., Forno, D., Zinnà, D., Maccario, M., Ghigo, E., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04055.x · Cited by 122
Tiganescu, A., Walker, E. A., Hardy, R. S., Mayes, A. E., & Stewart, P. M. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.257 · Cited by 122
Self-citationLocal and systemic glucocorticoid metabolism in inflammatory arthritis
Hardy, R., Rabbitt, E. H., Filer, A., Emery, P., Hewison, M., Stewart, P. M., Gittoes, N. J., Buckley, C. D., Raza, K., & Cooper, M. S. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.090662 · Cited by 118
Self-citationA Putative Hydroxysteroid Dehydrogenase Involved in Regulating Plant Growth and Development
Li, F., Asami, T., Wu, X., Tsang, E. W. T., & Cutler, A. J. (2007) · PLANT PHYSIOLOGY · doi:10.1104/pp.107.100560 · Cited by 129
“We studied an Arabidopsis gene that is annotated by the Munich Information Centre for Protein Sequences Arabidopsis Genome Database as a homolog of human and animal 11b-HSD, an enzyme that plays an important role in steroid metabolism (Tomlinson et al., 2004; McCormick et al., 2006).”
Keratinocytes synthesize and activate cortisol
Cirillo, N., & Prime, S. S. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23081 · Cited by 118
“The activation of cortisone occurs via 11bHydroxysteroid dehydrogenase (HSD) 1 (gene name HSD11B1), whereas the reverse, cortisol to cortisone, involves 11b-HSD2 [Tomlinson et al., 2004].”
β-Keto sulfones as inhibitors of 11β-hydroxysteroid dehydrogenase type I and the mechanism of action
Xiang, J. S., Ipek, M., Suri, V., Tam, M., Xing, Y., Huang, N., Zhang, Y., Tobin, J. F., Mansour, T. S., & McKew, J. C. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.04.035 · Cited by 126
Guo, L., & Tabrizchi, R. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.009 · Cited by 126
The Hypothalamic-Pituitary-Adrenal Axis: A Brief History
Miller, W. L. (2018) · Hormone Research in Paediatrics · doi:10.1159/000487755 · Cited by 124
Skobowiat, C., Sayre, R. M., Dowdy, J. C., & Slominski, A. T. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12096 · Cited by 115
Rose, A. J., Vegiopoulos, A., & Herzig, S. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.010 · Cited by 130
Shoener, J. A., Baig, R., & Page, K. C. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00757.2004 · Cited by 115
Agarwal, A. K., & Auchus, R. J. (2005) · Endocrinology · doi:10.1210/en.2005-0061 · Cited by 112
Pereira, C., Azevedo, I., Monteiro, R., & Martins, M. J. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01582.x · Cited by 126
“11β-HSD1 is bidirectional, able to act as both a reductase (activating glucocorticoids) and a dehydrogenase (oxidase, inactivating glucocorticoids) [3,13].”
Metadata
- Authors
- Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-10-01
- Volume
- 25
- Issue
- 5
- Pages
- 831-866
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2016125985
- Semantic Scholar
- 7653c899826b606d61172864887c634e9d76851b
- Cited by
- 969
- References
- 412
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 25 · 2023: 23 · 2022: 32 · 2021: 30 · 2020: 27 · 2019: 34 · 2018: 30 · 2017: 33 · 2016: 38 · 2015: 43 · 2014: 55 · 2013: 65 · 2012: 70
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, glucocorticoid metabolism, hexose-6-phosphate dehydrogenase, NADPH cofactor, tissue-specific gene regulation, obesity, metabolic syndrome, glaucoma, osteoporosis, 11β-HSD1 inhibition
- MeSH terms
- Amino Acid Sequence, Animals, Carbohydrate Dehydrogenases, Cloning, Molecular, Cortisone Reductase, Enzyme Inhibitors, Glaucoma, Glucocorticoids, Humans, Hydrocortisone, Molecular Sequence Data, Mutation, NADP, Obesity, Organ Specificity, Osteoporosis, Recombinant Proteins, Substrate Specificity, Transcription, Genetic, Gene Expression Regulation, Enzymologic, Sequence Alignment, 11-beta-Hydroxysteroid Dehydrogenase Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.